Nitric oxide, TNF-α and TGF-β formation of rat Kupffer cell activated by the β-glucan from Ganoderma lucidum

Korean Journal of Applied Microbiology and Biotechnology

Volumn 27, Issue 1, 1999, Pages 28-34

  Han, Man Deuk ^a   Lee, June Woo ^b   Jeong, Hoon ^b   Kim, Yong Seok ^b   Ra, Su Jung ^a   Yoon, Kyung Ha ^c  

^a Kimcheon College   (South Korea)

^b Biotechnology Lab   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

glucan; Kupffer cell; Nitric oxide; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

BETA GLUCAN; GANODERAN A; MANNAN; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; KUPFFER CELL; MACROPHAGE ACTIVATION; NONHUMAN; RAT;

GANODERMA LUCIDUM;

EID: 0032997858     PISSN: 02572389     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Adams, D. O. and T. A. Hamilton. 1984. The biology of macrophage activation. Ann. Rev. Immunol. 2: 283-318.
2. Adamson, I. Y. and D. H. Bowden. 1988. Relationship of alveolar epithelial injury and repair to induction of pulmonary fibrosis. Am. J. Pathol. 130: 377-383.
3. Agarwal, S., B. E. Drysdale, and H. S. Shin. 1988. Tumor necrosis factor-mediated cytotoxicity involved ADP-ribosylation. J. Immunol. 140: 4187-4192.
4. Billiar, T. R., R. D. Curran, F. K. Ferrari, D. Z. Williams, and R. L. Simmons. 1990. Kupffer cell: Hepatocyte cocultures release nitric oxide in response to bacterial endotoxin. J. Sur. Res. 48: 349-353.
5. Chun, Q. C., J. Assreuy, D. Xu, I. Charles, F. Y. Liew, and S. Moncada. 1993. Repeated induction of nitric oxide synthetase and leishmanicidal activity in murine macrophage. Eur. J. Immunol. 23: 1385-1388.
6. Decker. K. 1990. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192: 245-261.
7. Decker, T., M. J. Lohmann-Matthes, and G. Gifford. 1987. Cell associated tumor necrosis factor(TNF) as a killing mechanism of activated cytotoxic macrophage. J. Immunol. 138: 957-962.
8. Derynck, R., J. A. Jarrett, and E. A. Chen. 1985. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 316: 701.
9. Ding, A. J., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: Comparison of activating cytokines and evidence for independent production. J. Immunol. 144: 2407-2413.
10. Furchgott, R. F. and P. M. Vanhoutte. 1989. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol. 139: 19-30.
11. Halliwell, B. and J. M. C. Cutteridge. 1984. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical. J. 219: 1-14.
12. Han, M. D., E. S. Lee, Y, K. Kim, J. W. Lee, H Jeong, and K. H. Yoon. 1998. Production of nitric oxide in Raw 264.7 macrophages treated with Ganoderan, the β-glucan of Ganoderma lucidum. Kor. J. Mycol. 26(2): 246-255.
13. Han, M. D., H. Jeong, J. W. Lee, S. J. Back, S. U. Kim, and K. H. Yoon. 1995. The composition and bioactivities of Ganoderan by mycelial fractionation of Ganoderma lucidum IY009. Kor. J Mycol. 23(4): 285-297.
14. Han, M. D., J. W. Lee, H. Jeong, S. K. Chung, S. Y. Lee, and K. H. Yoon. 1995. The effects of carbon sources on antitumor and anticomplementary activities of Ganoderan extracted from the mycelium of Ganoderma lucidum IY009. Kor. J. Mycol. 23(3): 209-225.
15. Hornbeck, P. 1994. Current Protocol in Immunology, Unit 2.1. R. Coico (ed.). John Willey & Sons, Inc.
16. Ichinose, Y., O. Bakouche, T. Y. Tsao, and I. J. Fildler. 1988. Tumor necrosis factor and IL-1 associated with plasma membrane of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both. J. Immunol. 141: 512-518.
17. Konopski, Z., R. Seljelid, and T. Eskeland. 1994. IFN-γ inhibits internationalization of soluble aminated β-1,3-D-glucan by macrophages and thereby down-regulation the glucan induced release of TNF-α and IL-1. Scan. J. Immunol. 40: 57-63.
18. Lee, K. H., J. O. Lee, J. W. Lee, H. Jeong, M. D. Han, J. H. Jeong, and D. W. Oh. 1994. Pharmacological, toxicological studies of antitumor polysaccharides obtained from G. lucidum IY009. Kor. J. Appl. Microbiolo. Biotechnol. 22(2): 182-189.
19. Moncada, S. and A. Higgs. 1993. The argine-nitric oxide pathway. New Engl. J. Med. 329(27): 2002-2012.
20. Mosmann, T. 1985. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
21. Nakano, Y., K. Onozuka, Y. Terada, H. Shinomiya, and M. Nakano. 1990. Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis. J. Immunol. 144: 1935-1941.
22. - . Implication for the action of endothelial derived relaxation factor (EDRF). Free Rad. Res. Commun. 10: 221-226.
23. Roland, C. R., J. A. Goss, M. J. Mangino, D. Hafenrichter, and M. W. Flye. 1994. Autoregulation by eicosanoids of human Kupffer cell secretory products: A study of interleukin-1, interleukin-6, tumor necrosis factor-α, transforming growth factor-β, and nitric oxide. Annals of Sugery 219(4): 389-399.
24. Seglen, P. O. 1973. Preparation of isolated rat liver cells. III. Enzymatic requirements for tissue dispersion. Exp. Cell Res. 82: 391-398.
25. Sung, J., R. S. Nelson, and S. C. Silverstein. 1983. Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages. J. Cell Biol. 96: 160-166.
26. Suttles, J., J. G. Gin, and S. B. Mizel. 1990. IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium inophores. J. Immunol. 144: 175-182.
27. Williams, D. A., E. R. Sherwood, R. B. McNamee, E. L. Jones, and N. R. Di Luzio. 1985. Therapeutic efficacy of glucan in a murine model of hepatic metastatic disease. Hepatology 5(2): 198-206.